Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus.

PropertyValue
has major subject area list Apolipoproteins E; Atherosclerosis; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Naphthalenes; Propionates; Receptors, Thromboxane A2, Prostaglandin H2
information resource reference Zuccollo A, Shi C, Mastroianni R, Maitland-Toolan KA, Weisbrod RM, Zang M, Xu S, Jiang B, Oliver-Krasinski JM, Cayatte AJ, Corda S, Lavielle G, Verbeuren TJ, Cohen RA. The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus. Circulation. 2005 Nov 8; 112(19):3001-8. PMID: 16260636.
label The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus.

Highlights
Search Criteria
  • atherosclerosis